Nanotechnology may benefit lymphoma patients |
30/3/2007 |
Patients with lymphoma and other cancers may, in the future, benefit from a type of nanotechnology that helps track the growth of tumours and the effectiveness of chemotherapy. |
|
|
|
Virus hope for anti-lymphoma treatment |
16/3/2007 |
Researchers in the USA have discovered a way to activate the Epstein-Barr virus inside tumours, providing hope that such viruses can be manipulated to destroy the tumours that they inhabit. |
|
|
|
Breast cancer patients with history of lymphoma "under-treated" |
9/3/2007 |
The treatment of women with breast cancer who have a history non-Hodgkin's lymphoma or Hodgkin's disease needs to be improved, say researchers, who found that these women often fair worse than breast cancer patients without a history of these other cancers. |
|
|
|
Hope for lymphoma prevention in transplant patients |
16/2/2007 |
Study results suggest that a treatment used to protect against herpes-related infection may also protect against the early development of non-Hodgkin's lymphoma in patients who have undergone kidney transplants. |
|
|
|
Experimental drug shows promise for leukaemia patients |
16/2/2007 |
An experimental drug, called oblimersen, may benefit patients with chronic lymphocytic leukaemia who have relapsed after initial treatment by increasing their sensitivity to chemotherapy, researchers have found. |
|
|
|
Protein study may benefit leukaemia patients |
9/2/2007 |
UK researchers hope to find out whether measuring levels of a particular protein that switches genes on and off in leukaemia cells can be used to predict the best course of treatment for patients with chronic lymphocytic leukaemia. |
|
|
|
Arthritis strongly linked to lymphoma subtype |
26/1/2007 |
Results of a Swedish study show that the increased risk of non-Hodgkin's lymphoma associated with rheumatoid arthritis is particularly pronounced for a subtype of NHL called non-germinal centre diffuse large B cell lymphoma. |
|
|
|
Growth factor drug may increase bone loss |
19/1/2007 |
A type of medication called granulocyte colony-stimulating factor, which is used to reduce the toxic side effects of chemotherapy, may decrease bone mineral density and increase the risk of bone tumours, say US researchers. |
|
|
|
Allergies not linked to NHL |
19/1/2007 |
Results of a Scandinavian study indicate that contrary to previous belief, allergic diseases such as a hayfever do not influence an individual's risk of developing non-Hodgkin's lymphoma. |
|
|
|
Many people think cancer is down to 'fate' |
12/1/2007 |
Results of a UK survey indicate that many people believe their risk of developing cancer is a question of 'fate', and do not realise that their risk can be reduced through lifestyle changes. |
|
|
|
Drug may benefit elderly patients with DLBCL |
12/1/2007 |
Results of an Italian study suggest that the drug ibritumomab tiuxetan, when given after chemotherapy, may have significant benefits for elderly patients with diffuse large-B-cell lymphoma. |
|
|
|
Drug combination benefits CLL patients |
5/1/2007 |
Results of a US study suggest that treatment with a combination of the chemotherapy drugs pentostatin, cyclophosphamide and rituximab may have significant benefits for patients with previously untreated chronic lymphocytic leukaemia. |
|
|
|
Regulator of aggressive B-CLL gene discovered |
29/12/2006 |
The gene responsible for the most aggressive form of B-cell chronic lymphocytic leukaemia appears to be regulated by two microRNAs, a type of protein that could offer novel avenues for treatment, US study findings suggest. |
|
|
|
Epstein-Barr virus reduces peripheral T-cell lymphoma survival |
29/12/2006 |
People with peripheral T-cell lymphoma who are infected with Epstein-Barr virus have reduced overall survival in comparison with uninfected patients, particularly in the first 2 years after diagnosis, French researchers have discovered. |
|
|
|
Drug combination benefits CLL patients |
5/1/2007 |
Results of a US study suggest that treatment with a combination of the chemotherapy drugs pentostatin, cyclophosphamide and rituximab may have significant benefits for patients with previously untreated chronic lymphocytic leukaemia. |
|
|
|
Regulator of aggressive B-CLL gene discovered |
29/12/2006 |
The gene responsible for the most aggressive form of B-cell chronic lymphocytic leukaemia appears to be regulated by two microRNAs, a type of protein that could offer novel avenues for treatment, US study findings suggest. |
|
|
|
Epstein-Barr virus reduces peripheral T-cell lymphoma survival |
29/12/2006 |
People with peripheral T-cell lymphoma who are infected with Epstein-Barr virus have reduced overall survival in comparison with uninfected patients, particularly in the first 2 years after diagnosis, French researchers have discovered. |
|
|
|
Regulator of aggressive B-CLL gene discovered |
29/12/2006 |
The gene responsible for the most aggressive form of B-cell chronic lymphocytic leukaemia appears to be regulated by two microRNAs, a type of protein that could offer novel avenues for treatment, US study findings suggest. |
|
|
|
Epstein-Barr virus reduces peripheral T-cell lymphoma survival |
29/12/2006 |
People with peripheral T-cell lymphoma who are infected with Epstein-Barr virus have reduced overall survival in comparison with uninfected patients, particularly in the first 2 years after diagnosis, French researchers have discovered. |
|
|
|
Increased chemotherapy times may reduce heart risks |
24/11/2006 |
A review of published studies suggests that extending infusion times for chemotherapy to 6 hours or longer may help reduce the risk of heart problems associated with cancer drugs called anthracyclines. |
|
|
|
ER-CHOP 'effective' for newly diagnosed DLBCL patients |
24/11/2006 |
Chemotherapy that combines the drugs epratuzumab and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone is an effective and well-tolerated treatment for patients who have been newly diagnosed with diffuse large B-cell lymphoma, results of an initial study suggest. |
|
|
|
Rituximab improves survival in follicular NHL patients |
17/11/2006 |
Study results show that maintenance therapy with the drug rituximab may significantly improve the overall survival rates of patients with follicular non-Hodgkin's lymphoma who have either relapsed or failed to respond to previous treatment. |
|
|
|
Firefighters at increased risk of lymphoma |
17/11/2006 |
Firefighters have a higher risk of developing non-Hodgkin's lymphoma and three other types of cancer than the general population, results of a US study suggest. |
|
|
|
Complementary medicine use widespread among cancer patients |
10/11/2006 |
The use of complementary and alternative medicine is common among patients with lymphoma and other forms of cancer, say researchers who stress that doctors should make sure their patients know about the potential risks of combining such treatments with cancer therapy. |
|
|
|
Complementary medicine use widespread among cancer patients |
10/11/2006 |
The use of complementary and alternative medicine is common among patients with lymphoma and other forms of cancer, say researchers who stress that doctors should make sure their patients know about the potential risks of combining such treatments with cancer therapy. |
|
|
|
Early anaemia treatment improves quality of life for cancer patients |
27/10/2006 |
Results of a US study suggest that the early treatment of mild anaemia with the drug epoetin alfa, which stimulates the production of red blood cells, can significantly improve the quality of life of patients undergoing chemotherapy for non-Hodgkin’s lymphoma and other blood cancers. |
|
|
|
News Service Provided by Current Medicine Group
|